Mounjaro Pricing Explained: List Price, Coverage, and Cost Drivers

Welcome to the PlexusDx Education Hub, where GLP-1 therapy, weight management protocols, and the genetics behind every metabolic choice are explained in plain language. Browse all Peptides & GLP-1 education

Few GLP-1 questions come up as often as "what does Mounjaro actually cost?" The honest answer is that the sticker price and the number a patient ends up paying are rarely the same. This guide walks through the published list price, how insurance changes the math, the manufacturer and pharmacy savings routes, and where compounded tirzepatide fits, all reported as published figures as of April 2026 rather than promises.

What drives the price you actually pay

Four levers move Mounjaro out-of-pocket cost more than any others: whether your plan covers it, which FDA-approved indication the prescription is written for, whether a manufacturer savings card applies, and which pharmacy fills it. Because those levers combine differently for every patient, two people can leave the same pharmacy having paid wildly different amounts for identical medication.

The published list price

At U.S. list price, Mounjaro (tirzepatide) runs approximately $1,069 per month as of April 2026, per Eli Lilly published pricing. That list figure is the starting point, not the destination; most insured patients never pay it. It matters mainly as the ceiling that discounts, coverage, and savings programs work down from.

Where insurance fits

Coverage hinges on formulary placement and the indication on the prescription. Many commercial plans cover tirzepatide for type 2 diabetes, while coverage for chronic weight management tends to be narrower, frequently gated behind prior authorization or BMI-based criteria. The only reliable way to know your number is to check your specific plan directly as of April 2026.

Savings cards and pharmacy coupons

Eli Lilly publishes a manufacturer savings card that can meaningfully cut monthly cost for eligible commercially-insured patients. Separately, independent discount platforms such as GoodRx and SingleCare publish coupon prices that shift from pharmacy to pharmacy. Both eligibility rules and dollar amounts change over time, so confirm on the manufacturer site or with your pharmacy at the moment of fill.

The compounded tirzepatide angle

From 2022 through 2024 the FDA listed tirzepatide on its drug shortage list, which opened a regulatory lane for licensed 503A compounding pharmacies to prepare tirzepatide formulations. The FDA resolved that shortage in 2024, narrowing but not fully closing the pathway. When prescribed by a licensed clinician and filled through a state-licensed compounding pharmacy, legitimate compounded protocols remain a real option, though pricing and access vary widely.

PlexusDx runs its own clinician-supervised compounded GLP-1 protocols inside the Weight Management Protocols collection, spanning Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, Tirzepatide Oral, Microdose GLP-1, and GLP-Squared; each product page shows current pricing as of April 2026. Before any of those pricing decisions, though, the Precision Peptide Genetic Test maps 14 pathways, 49 peptides, 150+ genetic insights, reading variants such as FTO, GLP1R, and MC4R that set your baseline appetite-regulation, energy-balance, and GLP-1 biology. That is the test before you invest logic PlexusDx brings to every cost conversation.

Related reading on PlexusDx: Mounjaro Price, Mounjaro vs Zepbound, What is Mounjaro, Zepbound vs Mounjaro.

Disclaimer: This article is educational. PlexusDx offers tirzepatide through its Weight Management Protocols — this article covers the mechanism, evidence, and genetic context that informs any decision to use it. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Explore the PlexusDx Tirzepatide protocol or the oral tirzepatide protocol within the Weight Management Protocols collection, or begin upstream and take the Precision Peptide Genetic Test first.

Frequently Asked Questions

What is the cash price of Mounjaro without insurance?

At approximately $1,069 per month in U.S. list price as of April 2026 per Eli Lilly published pricing, that figure is roughly what uninsured, cash-pay patients face at most pharmacies without a savings card. Manufacturer programs, pharmacy discount cards, and compounded alternatives are the levers used to bring that number down.

Is a Mounjaro savings card or coupon available?

Yes. Eli Lilly publishes a manufacturer savings card that can substantially reduce monthly cost for eligible commercially-insured patients. Independent coupons through GoodRx and SingleCare list discounted prices that differ by pharmacy and change frequently. Confirm your eligibility and the current amount at the time you fill the prescription.

What makes Mounjaro this expensive?

Mounjaro is a patent-protected branded drug, and Eli Lilly sets list price around research cost recovery, market positioning, and expected payer mix. Prices have stayed high partly because demand outran manufacturing capacity across 2023 and 2024. Savings programs and compounded alternatives remain the main tools patients use to reduce spend.

Do compounded versions cost less?

Frequently, yes. Compounded tirzepatide prepared by licensed 503A pharmacies has historically been priced well under Mounjaro list price. The trade-offs are regulatory complexity, variability in prescriber oversight, and the FDA's evolving position on compounding after the 2024 shortage resolution. Discuss the specifics with a qualified clinician.

This guide is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education